These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11783675)

  • 1. Immunoproliferative small intestinal disease, two cases in the Northern Territory.
    Healey T; Olver I; Selva-Nayagam S
    Intern Med J; 2002; 32(1-2):47-9. PubMed ID: 11783675
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with tetracycline and aggressive supportive care for immunoproliferative small-intestinal disease lymphoma.
    el Saghir NS
    J Clin Oncol; 1995 Mar; 13(3):794-5. PubMed ID: 7884437
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we suppress the antigenic stimulus in IPSID for lifelong?
    Celik AF; Pamuk GE; Pamuk ON; Uzunismail H; Oktay E; Doğusoy G
    Am J Gastroenterol; 2000 Nov; 95(11):3318-20. PubMed ID: 11095373
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoproliferative small intestinal disease in Peru: treatment with oral tetracyclines.
    León-Barúa R
    Am J Med; 1991 Oct; 91(4):444-5. PubMed ID: 1951397
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoproliferative small intestinal disease in South India: a clinical and immunomorphological study.
    Nair S; Mathan M; Ramakrishna BS; Mathan VI
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1207-11. PubMed ID: 9918427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary low-grade lymphomas of the intestine. Case 1: immunoproliferative small intestinal disease.
    Demirer T; Celebi H; Akçağlayan E; Ustün C; Demirer S; Ekinci C; Bahar K; Koç H
    J Clin Oncol; 1999 Nov; 17(11):3682-4. PubMed ID: 10550167
    [No Abstract]   [Full Text] [Related]  

  • 7. Is immunoproliferative small intestinal disease uncommon in India?
    Ghoshal UC; Chetri K; Banerjee PK; Choudhuri G; Pal BB; Dabadghao S; Dhar K; Naik S; Naik SR
    Trop Gastroenterol; 2001; 22(1):14-7. PubMed ID: 11398237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
    Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
    Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary immunoproliferative small intestinal disease].
    Nardulli Fernández G; Sukerman V; Marsicano L; Ramón Poleo JR; Hernández D; Almosny I; Olavarría R
    G E N; 1995; 49(3):238-42. PubMed ID: 8598264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malabsorption associated with nonmalignant immunoproliferative small intestinal disease.
    Manousos O; Economidou J; Papademetriou C; Triantaphyllidis J; Constandinidou N; Stathopoulos A
    Digestion; 1987; 36(3):182-8. PubMed ID: 3596077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA abnormalities in Mediterranean lymphoma (alpha chain disease).
    Salem SN; Kanan MW; Lazarov B; Omar YT; Al-Awady H
    Postgrad Med J; 1972 May; 48(559):314-7. PubMed ID: 18557245
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary small-intestinal lymphomas in Taiwan: immunoproliferative small-intestinal disease and nonimmunoproliferative small-intestinal disease.
    Shih LY; Liaw SJ; Dunn P; Kuo TT
    J Clin Oncol; 1994 Jul; 12(7):1375-82. PubMed ID: 8021727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological evolution of alpha chain disease to immunoblastic lymphoma and response to COMP chemotherapy.
    Rogers P; Hill I; Sinclair-Smith C; Bowie M
    Med Pediatr Oncol; 1988; 16(2):128-31. PubMed ID: 3352536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoproliferative small intestinal disease (IPSID): an unusual form of gastrointestinal lymphoma].
    Zahner J; Kirchner T; Ott G; Schneider W
    Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1227-31. PubMed ID: 8052827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
    Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
    Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of epidemic polyarthritis (Ross River virus disease) in the Northern Territory during the 1990-1991 wet season.
    Tai KS; Whelan PI; Patel MS; Currie B
    Med J Aust; 1993 Apr; 158(8):522-5. PubMed ID: 8098129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
    Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
    Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The associations of factors with previous alcohol use in the Northern Territory compared to other states - an observational study.
    Treacy PJ; Rey-Conde T; Allen J; Maloney RT; North JB
    Aust N Z J Public Health; 2021 Dec; 45(6):578-583. PubMed ID: 34473384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoproliferative small intestinal disease: a case report and literature review].
    Xu SQ; Fang F; Zhou H
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):389-91. PubMed ID: 17706052
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's Northern Territory.
    Gear RJ; Carter JC; Carapetis JR; Baird R; Davis JS
    Trop Med Int Health; 2015 Jan; 20(1):40-7. PubMed ID: 25354844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.